Parameter | Rest | Maximal exercise | ||||||
Control | IPAH | CTEPH | ANOVA p-value | Control | IPAH | CTEPH | ANOVA p-value | |
Subjects n | 37 | 21 | 16 | 37 | 21 | 16 | ||
Pc,CO2 mmHg | 38.1 (32.0–42.1) | 31.7### (24.1–37.6) | 32.8### (27.1–38.2) | <0.001 | 37.5 (27.4–44.2) | 31.6### (22.8–39.0) | 29.5### (22.8–40.7) | <0.001 |
PET,CO2 mmHg | 35.8 (26.5–44.7) | 27.2*,### (20.4–35.0) | 22.7### (20.3–35.1) | <0.001 | 39.4 (26.3–48.3) | 28.3**,### (16.5–38.9) | 19.7### (13.8–34.0) | <0.001 |
Pc−ET,CO2 mmHg | 2.3 (-4.8–8.1) | 4.4*** (0.9–9.0) | 8.6### (3.0–13.7) | <0.001 | -1.9 (-5.7–6.2) | 4.1***,### (0.0–8.8) | 9.3### (3.3–13.1) | <0.001 |
VD/VT % | 42 (13–64) | 46** (29–61) | 58### (39–66) | <0.001 | 23 (5–51) | 35***,### (19–52) | 49### (29–57) | <0.001 |
Data are presented as median (range), unless otherwise stated. IPAH: idiopathic pulmonary arterial hypertension; CTEPH: chronic thromboembolic pulmonary hypertension; PET,CO2: end-tidal carbon dioxide tension; Pc–ET,CO2: capillary to end-tidal carbon dioxide gradient (Pc,CO2 – PET,CO2); VD: dead space volume (calculated according to Bohr’s formula); VT: tidal volume. ###: p<0.001 for difference from control; *: p<0.05 for difference between IPAH and CTEPH; **: p<0.01 for difference between IPAH and CTEPH; ***: p<0.001 for difference between IPAH and CTEPH.